Navigation Links
HeartWare Reports Third Quarter 2012 Results
Date:11/9/2012

FRAMINGHAM, Mass. and SYDNEY, Nov. 9, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $22.9 million for the third quarter ended September 30, 2012, compared to revenue of $21.3 million for the same period of 2011.  Revenue from international markets increased approximately 40% to $19.2 million in the third quarter of 2012, from $13.7 million in the third quarter of 2011.  U.S. revenue, which is presently derived from clinical trial activities, was $3.7 million in the third quarter of 2012, compared to $7.6 million in the third quarter of 2011, due to the completed enrollment of the Company's Destination Therapy clinical trial in the second quarter of this year.  Currency fluctuations decreased revenue by nine percent in the third quarter compared to the same period in 2011.

For the nine months ended September 30, 2012, revenues increased approximately 31% to $78.3 million, compared to $59.7 million in the first nine months of 2011, supported by 60% commercial revenue growth internationally.  Currency fluctuations decreased revenue by seven percent compared to the same period in 2011. 

"We are pleased to have maintained strong international growth, particularly during the summer months of Europe, as 214 HeartWare® Ventricular Assist Systems were sold outside the U.S. in the third quarter of 2012, a 51% increase compared to 142 in the third quarter of last year," noted Doug Godshall, President and Chief Executive Officer.  "With the completion of enrollment in our Destination Therapy study in the United States, domestic revenue was primarily limited to the remaining slots in the Continued Access Protocol in the Bridge
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. HeartWare Schedules Third Quarter Conference Call And Webcast
2. HeartWare Presentation at the UBS Global Life Sciences Conference to be Webcast
3. HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
4. HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
5. HeartWare Reports Second Quarter 2012 Results
6. HeartWare Completes Acquisition Of World Heart Corporation
7. HeartWare Schedules Second Quarter Conference Call And Webcast
8. HeartWare Names Peter F. McAree Chief Financial Officer
9. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
10. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
11. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a ... operations in China and ... release financial results for the second quarter of 2014 after ... 2014 (which will be Thursday morning, August 14, 2014 Shanghai ... relations section of the Company,s website at http://www.wuxiapptec.com ...
(Date:7/22/2014)... , July 22, 2014  Pressure ... "Company") and Parabase Genomics ("Parabase"), (together "the ... a strategic research and development agreement (the ... PBI will develop a front-end, sample preparation ... and newborn confirmatory testing process. The sample ...
(Date:7/22/2014)... PORT WASHINGTON, New York , ... Neue Partnerschaft für umfassenden ... gefährlichen Medikamenteneinwirkungen in Österreich    ... führender Anbieter von geschlossenen Transfersystemen (Closed System ... Medikus , einen Vertriebshändler und ...
Breaking Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 2Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 3Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 4Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2
... Nov. 1, 2011 Lexicon Pharmaceuticals, Inc. ... on discovering and developing breakthrough treatments for human disease, ... results for the three and nine months ended September ... studies of LX4211 and LX1032 have provided further validation ...
... Corporation (NASDAQ: VOLC ), a leading developer and ... to enhance the treatment of coronary and peripheral artery disease, ... increased 18 percent versus the third quarter of 2010. ... revenues of $85.8 million versus revenues of $72.9 million in ...
Cached Medicine Technology:Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 2Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 3Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 4Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 5Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 6Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 7Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 8Volcano Reports 18 Percent Increase in Total Third Quarter Revenues 2Volcano Reports 18 Percent Increase in Total Third Quarter Revenues 3Volcano Reports 18 Percent Increase in Total Third Quarter Revenues 4Volcano Reports 18 Percent Increase in Total Third Quarter Revenues 5Volcano Reports 18 Percent Increase in Total Third Quarter Revenues 6
(Date:7/22/2014)... July 22, 2014 Get Real ... Immune Deficiency Foundation (IDF) to provide their ... that will allow them to electronically track their symptoms, ... their illnesses. It will also allow those patients and ... consent to have their data shared with the ...
(Date:7/22/2014)... 22, 2014 JumpSoft, Inc., a ... automated recovery at the application level, today released ... to application-centric management. , Based on ... the report provides insights, context and depth regarding ... application and system uptime. London, Ink, a B2B ...
(Date:7/22/2014)... Recently, MyDressCity.com has excitedly launched a promotion for ... all people can get a discount, up to 60% off, ... the new range; all the new items are of top ... Quinceanera gowns for worldwide clients. Our dress specialists are always ... of MyDressCity.com, “Our Quinceanera dresses are selling well in the ...
(Date:7/22/2014)... July 22, 2014 BlackBox Biometrics, Inc. ... Gauge™ System with advancements including a new ... gauges represent a functional revision of the already robust ... capture complex data on blast events by recording a ... The extreme changes in overpressure that accompany a blast ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 "The Big Secrets: ... is one of the most important books young people can read. ... It will murder some of the “truths” people have been living ... what will the new truths be? From sex to death, this ... age 16 to 21, and it tells it like it is. ...
Breaking Medicine News(10 mins):Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 2Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 3Health News:Beautiful Dama Dresses Now Released By Popular Online Supplier MyDressCity.com 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 2Health News:BlackBox Biometrics®, Inc. continues to advance blast overpressure measurement with release of new Blast Gauge 3Health News:Strategic Book Publishing & Rights Agency Announces the Release of its Newest Title, “The Big Secrets: Ten Things Every Young Person Should Know About and Why” 2
... number of HIV cases in Africa as of last ... from the United Nations //.The World Health Organization has ... AIDS in Africa. ,The WHO has ... in healthcare in Africa could be used to give ...
... Science (RIMS) here is battling for life after doctors gave her ... to RIMS for a surgery, received B+ blood instead of her ... next 48 hours are critical for her. ,She was ... ago. Her condition worsened when she was given the wrong blood, ...
... replaced by a pill according to European researchers. The ... of the Grazax allergen tablet.// Hay fever and other ... ,Allergies are a result of the immune system reacting ... ,Immunotherapy is supposed to enhance tolerance of ...
... of people admitted into hospitals with diabetic related issues is ... of Health and Welfare.// ,The author of the report, ... and 2004, hospital admissions for diabetes increased by 20 per ... more people are being diagnosed with diabetes, it is increasing ...
... have found that a glass of orange juice every day ... citrus juices like lemonade. // ,The study that is ... 26 issue of the Clinical Journal of the American Society ... that all citrus fruit juices could help prevent the formation ...
... Australia are conducting a study involving 300 pairs of older ... ,'Even though we have twins that are identical, ... Sachdev said. 'By studying twins, we will be able to ... and which are environmental.' ,Prof Sachdev said that time ...
Cached Medicine News:Health News:A Glass of Orange Juice To Keep Recurrence Of Kidney Stones At Bay 2
Form should always follow function. Thats why EagleVision created the FlexPlug, the only tapered shaft punctum plug with contouring traction ribs. Designed to provide the ultimate in flexibility, fix...
The latest wave in punctum plugs! Unique design featureing reservoir indentations to reduce foreign body sensation. Elast™ - a proprietary formulated, hight performance Liquid Silicon Rubber ...
... Attain Prevail's steerable tip, along with various ... obtain the curve you need, when you ... visualization of the cardiac venous anatomy, adjust ... - Adjust curve and reach by ...
... Attain™ Deflectable Catheter - designed to be ... single catheter. Steerablility - Create a variety ... a single, steerable guide catheter. Lock the ... to address each patient's unique anatomy during ...
Medicine Products: